Nasdaq: ETRA · Listed Sep 18, 2026
Electra Therapeutics IPO
IPO price
$15.00
Electra Therapeutics (ETRA) priced its IPO at $15.00 a share and has traded on Nasdaq since Sep 18, 2026.
ETRA today$8.44-43.73%since IPO15-min delayed · as of 6:34:19 PM EST on Nov 18, 2026
See the ETRA quoteFirst trading day · Sep 18, 2026
- IPO price
- $15.00
- inside the range of $14 to $16
- First trade
- $15.00
- +0.00% from the IPO price
- First-day last trade
- $13.51
- -9.93% from the IPO price, regular session
- Raise
- $350M
- before the underwriters' option
These numbers are from the first trading day, Sep 18, 2026.
How ETRA did against the market
ETRA against the market, from its first trade at 12:00 ET to the last trade of the session.
- ETRA from its first trade
- -9.93%
- Against the market (QQQ)
- -10.6 pts
ETRA fell 9.9% from its first trade to the last trade of the session. That is 10.6 points worse than the market.
Same-day moves do not show that ETRA caused them. The market is QQQ, the Nasdaq-100 ETF.
The debut race
ETRA against other big listings, as the percent change from each stock's own IPO price.
The first 30 trading days. Each point is the last regular-session trade of a day.
The first trading day.
The first trading day.
The IPO scoreboard
ETRA against 6 other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.
| IPO | Raised | First trade | Day 1 close | Day 1 close, as a bar | Day 5 | Day 30 |
|---|---|---|---|---|---|---|
| Electra Therapeutics '26 | $350M | +0.00% | -9.93% | -21.20% | -42.47% | |
| Figma '25 | $1.22B | +157.58% | +252.42% | +173.64% | +69.64% | |
| Circle '25 | $1.05B | +122.58% | +168.45% | +278.18% | +622.98% | |
| Reddit '24 | $748M | +38.24% | +47.97% | +69.90% | +40.32% | |
| Arm '23 | $5.23B | +10.00% | +23.76% | +3.63% | -3.06% | |
| Klarna '25 | $1.37B | +30.00% | +16.14% | +13.73% | -7.33% | |
| CoreWeave '25 | $1.5B | -2.50% | +0.02% | +34.32% | +28.42% |
Day 1 is the last regular-session trade of the first day. Day 5 and day 30 are the last trade of the fifth and thirtieth trading day, counting the listing day as day 1. A cell fills in when that day has traded.
The offering
The Electra Therapeutics IPO offers 23.33M shares to raise $350M, before any underwriters' option.
- Expected price range
- $14 to $16
- IPO price
- $15.00
- Shares offered
- 23.33M
- Money raised
- $350M
- Listing date
- Sep 18, 2026
- Exchange
- Nasdaq
- Security
- Ordinary Shares
Money raised, against the largest IPOs
- Alibaba '14$21.77B
- Facebook '12$18.41B
- Rivian '21$11.93B
- Uber '19$8.1B
- Arm '23$5.23B
- Electra Therapeutics$350M
Where ETRA ranks
Electra Therapeutics's market cap against the largest US-listed companies.
Market cap, against the largest US-listed companies
- AAPL$5.12T
- MSFT$3.77T
- NVDA$3.65T
- GOOGL$3.47T
- AMZN$2.9T
- TSM$1.88T
- AVGO$1.69T
- META$1.58T
- TSLA$1.52T
- BRK.B$1.22T
- ETRA$529.13M
ETRA news
The latest news and headlines about Electra Therapeutics (ETRA).
- Kinzey Capital Management: Electra Sets Nasdaq IPO TermspositiveGlobeNewswire Inc.· Sep 19, 2026
Filings and the company
What Electra Therapeutics has disclosed to the SEC, and the basic facts about the listing.
8-K filings
Material events that Electra Therapeutics discloses to the SEC on Form 8-K.
- Quarterly earningsNov 12, 2026
On November 12, 2026, Electra Therapeutics, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended September 30, 2026.
- Public offeringSep 21, 2026
On September 21, 2026, the Company closed its IPO of an aggregate of 23,333,334 shares of common stock at a price to the public of $15.00 per share. The aggregate gross proceeds from the IPO, before deducting underwriting discounts and commissions and estimated offering expenses payable by the Company, were approximately $350.0 million.
About Electra Therapeutics
Electra Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines for the treatment of immune-mediated diseases and cancer. The company's pipeline includes Ipsoprubart and ELA822.
- Ticker
- ETRA
- Exchange
- Nasdaq
- Market
- stocks
- Type
- CS
- Currency
- USD
- Industry
- BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
- Listed
- Sep 18, 2026
- Security
- Ordinary Shares
Frequently asked questions
What was the Electra Therapeutics IPO price?
$15.00 a share.
When did Electra Therapeutics go public?
Electra Therapeutics listed on Nasdaq on Sep 18, 2026 under the ticker ETRA.
How much did the Electra Therapeutics IPO raise?
$350M, before any underwriters' option.
How did Electra Therapeutics open on its first day?
ETRA first traded at $15.00, +0.00% from the IPO price of $15.00.
How did ETRA close on its first day?
Its last regular-session trade was $13.51, -9.93% from the IPO price of $15.00.
What was the ETRA first-day trading range?
$13.31 to $15.50 in the regular session.
How many ETRA shares traded on the first day?
4.88M shares in the regular session.
How many shares did Electra Therapeutics sell in its IPO?
23.33M shares.
How did ETRA do against the market on its first day?
ETRA fell 9.9% from its first trade to the last trade of the session. That is 10.6 points worse than the market (QQQ, the Nasdaq-100 ETF).
What exchange is ETRA listed on?
Electra Therapeutics lists on Nasdaq under the ticker ETRA.
Build with Massive
Get the ETRA data behind this page
| What the page shows | Endpoint |
|---|---|
| Offering terms and dates | /vX/reference/ipos |
| Price | /v3/snapshot |
| Chart, VWAP, and the market comparison | /v2/aggs/ticker/ETRA/range/5/minute |
| Market cap | /v3/reference/tickers/ETRA |
| News | /v2/reference/news |
| Filings | /vX/disclosures |
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.